21,922 Shares in Ryan Specialty Holdings, Inc. (NYSE:RYAN) Purchased by New Age Alpha Advisors LLC

New Age Alpha Advisors LLC purchased a new position in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 21,922 shares of the company's stock, valued at approximately $1,407,000.

Other hedge funds have also recently modified their holdings of the company. Sanctuary Advisors LLC grew its position in Ryan Specialty by 1.2% during the 4th quarter. Sanctuary Advisors LLC now owns 15,690 shares of the company's stock worth $1,045,000 after purchasing an additional 188 shares during the last quarter. State of Alaska Department of Revenue lifted its stake in shares of Ryan Specialty by 1.6% during the fourth quarter. State of Alaska Department of Revenue now owns 12,130 shares of the company's stock worth $778,000 after buying an additional 190 shares during the period. CIBC Asset Management Inc grew its holdings in shares of Ryan Specialty by 5.6% during the fourth quarter. CIBC Asset Management Inc now owns 3,674 shares of the company's stock valued at $236,000 after buying an additional 196 shares during the last quarter. Exchange Traded Concepts LLC increased its position in shares of Ryan Specialty by 2.6% in the 4th quarter. Exchange Traded Concepts LLC now owns 11,760 shares of the company's stock valued at $755,000 after acquiring an additional 295 shares during the period. Finally, UMB Bank n.a. raised its stake in Ryan Specialty by 5.7% in the 4th quarter. UMB Bank n.a. now owns 5,522 shares of the company's stock worth $354,000 after acquiring an additional 298 shares during the last quarter. Institutional investors and hedge funds own 84.82% of the company's stock.

Ryan Specialty Price Performance

Shares of Ryan Specialty stock traded down $5.38 during mid-day trading on Friday, reaching $70.55. 1,434,020 shares of the stock traded hands, compared to its average volume of 932,203. The stock has a market capitalization of $18.48 billion, a PE ratio of 102.25, a PEG ratio of 1.19 and a beta of 0.71. The business has a 50-day moving average of $69.60 and a 200 day moving average of $68.60. Ryan Specialty Holdings, Inc. has a fifty-two week low of $48.48 and a fifty-two week high of $77.16. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 2.40.

Ryan Specialty (NYSE:RYAN - Get Free Report) last posted its quarterly earnings data on Thursday, February 20th. The company reported $0.45 EPS for the quarter, missing the consensus estimate of $0.47 by ($0.02). Ryan Specialty had a net margin of 9.14% and a return on equity of 48.01%. The firm had revenue of $663.53 million during the quarter, compared to analyst estimates of $658.80 million. On average, analysts predict that Ryan Specialty Holdings, Inc. will post 2.29 EPS for the current year.

Ryan Specialty Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Tuesday, March 4th were paid a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a yield of 0.68%. The ex-dividend date was Tuesday, March 4th. This is a boost from Ryan Specialty's previous quarterly dividend of $0.11. Ryan Specialty's dividend payout ratio is currently 69.57%.

Analyst Ratings Changes

Several analysts have weighed in on the company. Royal Bank of Canada dropped their price target on Ryan Specialty from $73.00 to $72.00 and set a "sector perform" rating on the stock in a research note on Friday, February 21st. UBS Group upped their target price on Ryan Specialty from $82.00 to $84.00 and gave the company a "buy" rating in a research report on Wednesday, February 26th. Wells Fargo & Company raised their price target on shares of Ryan Specialty from $64.00 to $69.00 and gave the stock an "equal weight" rating in a research report on Friday, February 21st. Keefe, Bruyette & Woods dropped their price objective on shares of Ryan Specialty from $77.00 to $76.00 and set an "outperform" rating on the stock in a report on Friday, February 21st. Finally, Morgan Stanley assumed coverage on shares of Ryan Specialty in a report on Thursday, December 5th. They set an "overweight" rating and a $90.00 target price for the company. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and six have issued a buy rating to the company's stock. According to data from MarketBeat.com, Ryan Specialty presently has an average rating of "Hold" and an average price target of $75.27.

Insider Buying and Selling at Ryan Specialty

In related news, EVP Brendan Martin Mulshine sold 30,000 shares of the company's stock in a transaction dated Friday, March 14th. The shares were sold at an average price of $69.30, for a total value of $2,079,000.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock in a transaction dated Wednesday, January 15th. The stock was sold at an average price of $65.99, for a total transaction of $2,309,650.00. Following the transaction, the director now directly owns 35,609 shares in the company, valued at $2,349,837.91. This trade represents a 49.57 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 241,360 shares of company stock worth $16,006,428. Insiders own 11.10% of the company's stock.

Ryan Specialty Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.